HRV in Autonomic Assessment - PhysioNet

More documents

Recommendations

Info

VALSALVA MANOEUVRE „ Intrathoracic pressure: 20-60mm Hg „ Duration of expiration: 7-207 sec. „ Open glottis „ Phase of respiration „ Patient cooperation „ Number of trials „ Age „ Sympathetic activity „ Severe proliferative ret<strong>in</strong>opathy „ Reproducibility
CARDIAC PARASYMPATHETIC FUNCTION Heart rate variability <strong>in</strong> response to: ƒ Respiration ƒ Valsalva manoeuvre ƒ Postural change ƒ Apneic facial immersion
Page 1 and 2: HRV in Diabetes and Other Disorders
Page 3 and 4: Survival % 100 80 60 Gen population
Page 5 and 6: Neuropathy prevalence Rochester Dia
Page 7 and 8: Prevalence of abnormal R-R variatio
Page 9 and 10: Mortality of autonomic neuropathy A
Page 11 and 12: Sudden cardiac death „ 21 cases o
Page 13 and 14: Risk factors for cardiac autonomic
Page 15 and 16: CARDIAC PARASYMPATHETIC FUNCTION He
Page 17 and 18: SINUS ARRHYTHMIA „ Respiratory fr
Page 19 and 20: EI_JC.WDQ Respiration Finapres BP P
Page 21 and 22: Time domain statistical measures of
Page 23 and 24: Simulation of the effect of mean he
Page 25: VALSALVA MANOEUVRE „ Stimulus: Ex
Page 29: 145 139 VAL2_HL.WDQ 78 Valsalva Rat
Page 33 and 34: 107 61 Measurements • "30:15" rat
Page 35 and 36: Supine Tilt
Page 37 and 38: Power spectral analysis of heart ra
Page 39 and 40: Power spectral analysis of heart ra
Page 41 and 42: Sympathetic neurotransmission • B
Page 43 and 44: Transfer function analysis of respi
Page 45 and 46: Heart rate power spectrum HR PSD [b
Page 48 and 49: Postural tachycardia Terminology
Page 50 and 51: Orthostatic tachycardia 140 BP mmHg
Page 52 and 53: Orthostatic intolerance Features
Page 54 and 55: Baroreflex response - Control 1200
Page 56 and 57: Cardiac Vagal Baroreflex Gain 30 (m

HRV in Autonomic Assessment - PhysioNet

Create successful ePaper yourself

Delete template?

Save as template?